Cancer Incidence and Mortality among Non-Hispanic Black Individuals, New York State Excl New York City, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Incidence | Mortality | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 4,962.0 | 481.7 | 475.6-487.9 | 2,565.8 | 567.5 | 557.2-577.9 | 2,396.2 | 423.8 | 416.1-431.6 | 1,525.6 | 155.3 | 151.7-158.9 | 753.6 | 186.8 | 180.6-193.2 | 772.0 | 135.9 | 131.6-140.3 |
Oral cavity and pharynx | 86.8 | 8.2 | 7.4-9.0 | 57.6 | 12.1 | 10.7-13.6 | 29.2 | 5.1 | 4.3-6.1 | 20.8 | 2.0 | 1.6-2.4 | 15.8 | 3.5 | 2.8-4.4 | 5.0 | 0.8 | 0.5-1.3 |
Esophagus | 38.0 | 3.9 | 3.3-4.5 | 24.2 | 6.1 | 5.0-7.4 | 13.8 | 2.4 | 1.8-3.0 | 29.4 | 3.0 | 2.5-3.5 | 20.8 | 5.3 | 4.3-6.5 | 8.6 | 1.5 | 1.0-2.0 |
Stomach | 110.8 | 11.3 | 10.4-12.3 | 57.0 | 13.5 | 11.9-15.3 | 53.8 | 9.7 | 8.6-11.0 | 43.6 | 4.5 | 3.9-5.1 | 24.6 | 6.0 | 4.9-7.2 | 19.0 | 3.4 | 2.7-4.1 |
Colorectal | 411.8 | 40.8 | 39.0-42.6 | 212.0 | 48.8 | 45.8-52.0 | 199.8 | 35.2 | 33.1-37.5 | 143.6 | 14.5 | 13.4-15.6 | 75.8 | 18.3 | 16.4-20.4 | 67.8 | 11.9 | 10.7-13.3 |
Colon excluding rectum | 298.0 | 29.8 | 28.3-31.4 | 145.8 | 34.3 | 31.7-37.0 | 152.2 | 26.9 | 25.0-28.9 | 119.0 | 12.1 | 11.1-13.1 | 62.2 | 15.2 | 13.5-17.1 | 56.8 | 10.0 | 8.8-11.2 |
Rectum & rectosigmoid | 113.8 | 11.0 | 10.1-11.9 | 66.2 | 14.5 | 12.9-16.2 | 47.6 | 8.4 | 7.3-9.5 | 24.6 | 2.5 | 2.0-2.9 | 13.6 | 3.1 | 2.4-4.0 | 11.0 | 2.0 | 1.5-2.6 |
Liver / intrahepatic bile duct | 119.6 | 10.8 | 9.9-11.7 | 86.0 | 17.5 | 15.8-19.3 | 33.6 | 5.5 | 4.7-6.5 | 79.6 | 7.6 | 6.9-8.4 | 54.4 | 11.8 | 10.4-13.3 | 25.2 | 4.4 | 3.6-5.2 |
Pancreas | 170.4 | 17.2 | 16.0-18.4 | 80.2 | 18.8 | 16.9-20.8 | 90.2 | 15.9 | 14.4-17.4 | 128.0 | 13.1 | 12.1-14.2 | 61.4 | 14.8 | 13.1-16.6 | 66.6 | 11.8 | 10.6-13.2 |
Larynx | 33.8 | 3.2 | 2.7-3.7 | 26.4 | 5.7 | 4.8-6.8 | 7.4 | 1.2 | 0.9-1.7 | 10.6 | 1.0 | 0.8-1.3 | 8.6 | 2.0 | 1.4-2.7 | 2.0 | 0.3 | 0.2-0.6 |
Lung and bronchus | 569.8 | 56.1 | 54.0-58.2 | 294.8 | 69.4 | 65.7-73.2 | 275.0 | 47.2 | 44.7-49.8 | 315.2 | 31.6 | 30.0-33.2 | 175.8 | 43.3 | 40.3-46.4 | 139.4 | 23.9 | 22.1-25.7 |
Melanoma of the skin | 10.4 | 1.1 | 0.8-1.4 | 4.2 | 1.0 | 0.6-1.6 | 6.2 | 1.1 | 0.7-1.6 | 2.0 | 0.2 | 0.1-0.4 | 1.0 | 0.2 | 0.1-0.6 | 1.0 | 0.2 | 0.1-0.4 |
Female breast | 747.0 | 133.6 | 129.3-138.1 | 137.4 | 24.4 | 22.6-26.4 | ||||||||||||
Cervix uteri | 43.0 | 7.8 | 6.8-9.0 | 14.0 | 2.5 | 1.9-3.2 | ||||||||||||
Corpus uterus and NOS | 187.4 | 31.8 | 29.7-33.9 | 52.2 | 9.0 | 7.9-10.2 | ||||||||||||
Ovary | 46.6 | 8.2 | 7.2-9.4 | 28.0 | 5.0 | 4.2-5.9 | ||||||||||||
Prostate | 1,021.6 | 215.8 | 209.6-222.1 | 103.2 | 29.1 | 26.6-31.8 | ||||||||||||
Testis | 9.4 | 1.8 | 1.3-2.4 | 0.0 | 0.0 | 0.0-0.2 | ||||||||||||
Urinary bladder (incl. in situ) | 127.8 | 13.0 | 12.0-14.0 | 86.4 | 21.1 | 19.1-23.3 | 41.4 | 7.3 | 6.4-8.4 | 25.2 | 2.8 | 2.3-3.3 | 15.4 | 4.4 | 3.5-5.6 | 9.8 | 1.7 | 1.3-2.3 |
Kidney and renal pelvis | 201.4 | 19.4 | 18.2-20.6 | 128.4 | 27.4 | 25.2-29.7 | 73.0 | 13.0 | 11.7-14.4 | 23.8 | 2.4 | 2.0-2.9 | 14.8 | 3.4 | 2.7-4.3 | 9.0 | 1.7 | 1.2-2.2 |
Brain and other central nervous system | 42.4 | 4.1 | 3.6-4.7 | 22.0 | 4.7 | 3.8-5.7 | 20.4 | 3.7 | 3.0-4.5 | 25.8 | 2.5 | 2.1-3.0 | 12.6 | 2.6 | 2.0-3.3 | 13.2 | 2.4 | 1.8-3.0 |
Thyroid | 104.6 | 10.2 | 9.4-11.2 | 21.6 | 4.7 | 3.8-5.7 | 83.0 | 15.4 | 14.0-17.0 | 6.0 | 0.7 | 0.4-0.9 | 2.6 | 0.7 | 0.3-1.2 | 3.4 | 0.6 | 0.4-1.0 |
Hodgkin lymphoma | 29.6 | 2.8 | 2.4-3.3 | 14.6 | 3.0 | 2.3-3.8 | 15.0 | 2.7 | 2.1-3.4 | 2.2 | 0.2 | 0.1-0.4 | 1.8 | 0.4 | 0.2-0.8 | 0.4 | 0.1 | 0.0-0.2 |
Non-Hodgkin lymphomas | 161.8 | 16.0 | 14.9-17.2 | 88.8 | 19.8 | 17.9-21.8 | 73.0 | 13.1 | 11.7-14.5 | 40.2 | 4.1 | 3.5-4.7 | 23.6 | 5.7 | 4.6-6.8 | 16.6 | 3.0 | 2.4-3.7 |
Myeloma | 151.4 | 15.1 | 14.0-16.2 | 77.4 | 18.2 | 16.3-20.2 | 74.0 | 12.9 | 11.6-14.3 | 48.6 | 5.2 | 4.6-5.9 | 25.0 | 6.8 | 5.6-8.1 | 23.6 | 4.3 | 3.5-5.1 |
Leukemias | 113.6 | 11.3 | 10.3-12.2 | 59.6 | 13.6 | 12.0-15.3 | 54.0 | 9.7 | 8.5-10.9 | 51.0 | 5.3 | 4.6-6.0 | 26.4 | 6.6 | 5.4-7.9 | 24.6 | 4.4 | 3.7-5.3 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.